Alector, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Alector, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 97% of Healthcare companies in United States.
- Cash Cushion Ratio: Cash, after subtracting all debt, is 1.1 times its market value (net cash). Higher than 89% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 87% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-162.7×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 87% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 84%
Sales fell 84% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-84% / -63%In 3 years sales changed by -84% while total assets changed by -63%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-502.8×Operating cash was negative last year, while some debt falls due within a year.
Lower than 97% of Healthcare companies in United States.
Cash Cushion Ratio
1.1× cashCash, after subtracting all debt, is 1.1 times its market value (net cash).
Higher than 89% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Alector, Inc. made a loss over the last year. Alector, Inc. owes $1.05 for every $1 it owns. Alector, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAlector, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-20.49Alector, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$204 MThe total market value of all of Alector, Inc.'s shares at today's price (share price × number of shares), smaller than 58% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
NegativeAlector, Inc.'s net worth is negative ($10 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Return on equity (ROE)
-385.1%Alector, Inc. lost 385.1% of its shareholders' money over the last year, lower than 91% of Healthcare companies in United States.
Owes vs Owns
1.05×Alector, Inc. owes $1.05 for every $1 it owns, so it owes more than it owns, higher than 88% of Healthcare companies in United States.
Dividend yield
NoneAlector, Inc. does not currently pay a dividend.
Revenue growth
-79%Revenue fell 79% in the year to Dec 2025, and shrank 46% a year on average over 3 years.
Profit growth
LossAlector, Inc. made a loss in each of the last two years.
Profit margin
-679.2%Alector, Inc. lost $679 for every $100 of revenue.
Cash vs debt
Net cashAlector, Inc. held $220 M more cash than debt (net cash) at Dec 2025.
Questions
What is Alector, Inc.'s return on equity?
Alector, Inc. lost 385.1% of its shareholders' money over the last year, lower than 91% of Healthcare companies in United States.
How much does Alector, Inc. owe compared with what it owns?
Alector, Inc. owes $1.05 for every $1 it owns, so it owes more than it owns, higher than 88% of Healthcare companies in United States.
Does Alector, Inc. pay a dividend?
No. Alector, Inc. does not currently pay a dividend.
Is Alector, Inc.'s revenue growing?
Revenue fell 79% in the year to Dec 2025, and shrank 46% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.